SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories informs about press release

04 May 2021 Evaluate
Morepen Laboratories has informed that it has enclosed press release on the financial performance of the Company for the quarter and financial year ended 31st March, 2021 with the title - ‘Morepen records stellar 189% jump in Net Profits and 39% growth in the Revenue in FY21 - Company to setup world class R&D Centre at Baddi (HP)’.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

41.59 -0.33 (-0.79%)
20-Apr-2026 15:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.40
Dr. Reddys Lab 1235.00
Cipla 1233.70
Zydus Lifesciences 939.55
Lupin 2328.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×